Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure
- PMID: 15283946
- DOI: 10.1016/j.drugalcdep.2004.03.012
Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure
Abstract
Maternal tobacco consumption during pregnancy has been associated with lower birth weight infants, preterm births, intrauterine growth retardation, smaller head circumference and increase in morbidity, yet few studies have examined the role tobacco has on the opiate neonatal abstinence syndrome (NAS). This study examined the effect of prenatal tobacco exposure on NAS for infants born to mothers maintained on methadone during gestation. Twenty-nine pregnant women and their newborn infants participated in this study. Tobacco exposure was based on maternal self-report with 16 women reporting cigarette consumption of 10 or less per day and 13 reporting smoking 20 cigarettes or more a day. The onset, peak, and duration of NAS were examined. Results showed that infants born to mothers who reported smoking 20 or more cigarettes per day had significantly higher NAS peak scores of 9.8 versus 4.8, and took longer to peak (113.0 h versus 37.8 h), than light smokers of 10 or fewer cigarettes per day. We concluded that tobacco use in conjunction with methadone plays an important role in the timing and severity of NAS in prenatally exposed infants.
Similar articles
-
Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers. Implications for treatment.Eur Addict Res. 2009;15(3):150-6. doi: 10.1159/000216466. Epub 2009 May 7. Eur Addict Res. 2009. PMID: 19420947
-
Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.BJOG. 2009 Apr;116(5):665-71. doi: 10.1111/j.1471-0528.2008.02073.x. Epub 2009 Feb 10. BJOG. 2009. PMID: 19220239
-
Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.Aust N Z J Obstet Gynaecol. 2010 Jun;50(3):253-8. doi: 10.1111/j.1479-828X.2010.01168.x. Aust N Z J Obstet Gynaecol. 2010. PMID: 20618243
-
Prenatal narcotic exposure: perinatal and developmental effects.Neurotoxicology. 1989 Fall;10(3):597-604. Neurotoxicology. 1989. PMID: 2696902 Review.
-
Methadone during pregnancy: the search for a valid animal model.Ann Ist Super Sanita. 1993;29(3):439-44. Ann Ist Super Sanita. 1993. PMID: 8172463 Review.
Cited by
-
The Negative Impact of Maternal Perinatal Opioid Use on Neonatal Outcomes.Prim Care Companion CNS Disord. 2021 Jun 10;23(3):20m02737. doi: 10.4088/PCC.20m02737. Prim Care Companion CNS Disord. 2021. PMID: 34115451 Free PMC article.
-
A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome.Pediatrics. 2014 Aug;134(2):e527-34. doi: 10.1542/peds.2013-4036. Pediatrics. 2014. PMID: 25070317 Free PMC article.
-
The Finnegan Score for Neonatal Opioid Withdrawal Revisited With Routine Electronic Data: Retrospective Study.JMIR Pediatr Parent. 2024 Feb 28;7:e50575. doi: 10.2196/50575. JMIR Pediatr Parent. 2024. PMID: 38456232 Free PMC article.
-
Illicit drug use among pregnant women enrolled in treatment for cigarette smoking cessation.Nicotine Tob Res. 2013 May;15(5):987-91. doi: 10.1093/ntr/nts220. Epub 2012 Oct 15. Nicotine Tob Res. 2013. PMID: 23072871 Free PMC article. Clinical Trial.
-
Opioid dependent and pregnant: what are the best options for mothers and neonates?Obstet Gynecol Int. 2012;2012:195954. doi: 10.1155/2012/195954. Epub 2012 Feb 7. Obstet Gynecol Int. 2012. PMID: 22496696 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources